Pharmacokinetics of florfenicol in the plasma of Japanese quail
dc.contributor.author | Koc, F. | |
dc.contributor.author | Uney, K. | |
dc.contributor.author | Ozturk, M. | |
dc.contributor.author | Kadioglu, Y. | |
dc.contributor.author | Atila, A. | |
dc.date.accessioned | 2020-03-26T17:39:38Z | |
dc.date.available | 2020-03-26T17:39:38Z | |
dc.date.issued | 2009 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | AIM: To determine the pharmacokinetics and bioavailability of florfenicol in the plasma of healthy Japanese quail (Coturnix japonica). METHODS: Sixty-five quail were given an I/V and I/M dose of florfenicol at 30 mg/kg bodyweight (BW). A two-period sequential design was used, with a wash-out period of 2 weeks between the different routes of administration. Concentrations of florfenicol in plasma were determined using high-performance liquid chromatography (HPLC). RESULTS: A naive pooled data analysis approach for the plasma concentration-time profile of florfenicol was found to fit a non-compartmental open model. After I/V administration, the mean residence time (MRT), mean volume of distribution at steady state (V(ss)), and total body clearance of florfenicol were 12.0 (SD 0.37) h, 8.7 (SD 0.22) L/kg, and 1.3 (SD 0.08) L/h/kg, respectively. After I/M injection, the MRT, mean absorption time (MAT), and bioavailability were 12.3 (SD 0.37) h, 0.2 (SD 0.02) h, and 79.1 (SD 1.79)%, respectively. CONCLUSIONS: The time for the concentration of florfenicol to fall below the probable effective concentration of 1 mu g/ml of approximately 10 h is sufficient for the minimum inhibitory concentration needed for many bacterial isolates. Further pharmacodynamic studies in quail are needed to evaluate a suitable dosage regimen. | en_US |
dc.identifier.doi | 10.1080/00480169.2009.64734 | en_US |
dc.identifier.endpage | 391 | en_US |
dc.identifier.issn | 0048-0169 | en_US |
dc.identifier.issue | 6 | en_US |
dc.identifier.pmid | 19966901 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 388 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1080/00480169.2009.64734 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/23758 | |
dc.identifier.volume | 57 | en_US |
dc.identifier.wos | WOS:000273349900014 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | NEW ZEALAND VETERINARY ASSOC INC | en_US |
dc.relation.ispartof | NEW ZEALAND VETERINARY JOURNAL | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | Pharmacokinetic | en_US |
dc.subject | florfenicol | en_US |
dc.subject | quail | en_US |
dc.subject | plasma | en_US |
dc.subject | bioavailability | en_US |
dc.title | Pharmacokinetics of florfenicol in the plasma of Japanese quail | en_US |
dc.type | Article | en_US |